Publications 2002

Aigner A, Ray P E, Czubayko F, Wellstein A.
Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development.
Histochem Cell Biol 117 (2002) 1-11

Aigner A, Renneberg H, Bojunga J, Apel J, Nelson P, Czubayko F.
Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo.
Oncogene 21(37) (2002) 5733-42

Aigner A, Fischer D, Merdan T, Brus C, Kissel T, Czubayko F.
Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression.
Gene Ther 9(24) (2002) 1700-1707

Krüger M, Regenthal R, Böhm R, Lindner D, Trauer H, Caffier P:
Letale Diethylenglykol-Intoxikation nach missbräuchlicher Anwendung von Goldgeist® forte.
Anästhesiologie und Intensivmedizin 43 (2002) 21-26.

Jäger R, List B, Knabbe C, Souttou B, Raulais D, Zeiler T, Wellstein A, Aigner A, Neubauer A, Zugmaier G.
Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients. Jäger R1, List B, Knabbe C, Souttou B, Raulais D, Zeiler T, Wellstein A, Aigner A, Neubauer A, Zugmaier G.
Br J Cancer 86 (2002) 858-863

Ludewig R, Preiss R, Regenthal R, Illes P, Kleemann WJ, Krüger N, Schreinicke G:
Aktuelles zu Arzneimitteln und Giften. Ärzteblatt Sachsen 11 (2002) 530-535.

Preiss R, Schmidt R, Baumann F, Hanschmann H, Hauss J, Geissler F, Pahlig H, Ratzewiss B:
Measurement of 4-hydroxylation of ifosfamide in human liver microsomes using the estimation of free and protein-bound acrolein and codetermination of keto- and carboxyifosfamide.
J Cancer Res Clin Oncol 128 (2002) 385-392.

Preiss R:
Antidepressiva und obere gastrointestinale Blutung.
Arzneiverordnung in der Praxis 1 (2002) 16.

Regenthal R, Krüger M, Trauer H, Boehm R, Preiss R:
Evaluation of REMEDI HS in the diagnosis of dimethoate poisoning.
Therapeutic Drug Monitoring 24 (2002) 297-301.

Regenthal R, Preiss R:
Telithromycin (Ketek®). Arzneimittelverordnung in der Praxis 2 (2002) 10.

Regenthal R, Stefanovic D, Albert T, Trauer H, Wolf T:
The pharmacologic stability of 35-years old theophylline.
Hum Exp Toxicol 21 (2002) 343-346.

Powers C, aigner A, Stoica G E, McDonnell K, Wellstein A.
Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.
J Biol Chem 277(16) (2002) 14153-14158

Teichert J, Preiss R:
High-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urine.
J Chromatogr B 769 (2002) 269-281.